Post-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical Practice

• Status: Unknown status
• Trial end date: 2014-04-01
• Target enrollment: 0
• Participant gender: All

Summary

A Drug Utilisation Survey is performed to monitor and document the drug utilisation patterns of Samsca in routine medical practice.

A Post-Authorisation Safety Study is performed to collect information on the safety of Samsca when used in a real-life setting.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Otsuka Frankfurt Research Institute GmbH
• Treatments: Tolvaptan

Criteria

Inclusion Criteria:

• Patients who are treated with Samsca

Exclusion Criteria:

• Patients who have not signed the data consent form